bpc-157 safety concerns fda panel votes to place popular peptide on compounding list 💊FDA Approval Update | #FDA

Mistake 4: not cleaning the vial stoppers Every time you insert a needle through the rubber stopper, it can push surface bacteria into the solution

Who should administer HYCOMIN and what are the precautions

Making migraine easier to stomach: the role of the gut-brain-immune axis in headache disorders

Electrophysiology results Based on a well-known phenomenon in peripheral nerve injury (i.e., as the number of preserved motoneurons decreases, the MUP (giant potential) in the tail muscle increases), it is conceivable that the BPC 157-treated rats that underwent spinal cord injury and were subjected to EMG recordings exhibited a markedly lower MUP in the tail muscle than that in the corresponding controls (Table 3)